COVID Associated with Up to 72% Increase in Type 1 Diabetes Diagnosis for Children
Children who were infected with COVID show a substantially higher risk of developing type 1 diabetes (T1D), according to a new study.
Children who were infected with COVID show a substantially higher risk of developing type 1 diabetes (T1D), according to a new study.
Abbott is developing a new biowearable that will continuously monitor glucose and ketone levels in one sensor.
Engineers have developed a prototype of such a wearable device that can continuously monitor glucose, alcohol, and lactate levels.
Measurement of dozens of types of fats in the blood can predict the risk of developing type 2 diabetes and cardiovascular disease years before their onset.
Read MoreThe ELF Test is a blood test that assesses prognosis in patients with advanced fibrosis due to non-alcoholic steatohepatitis (NASH).
Read MoreThe FDA Program will provide Life Science Biosensor Diagnostics with a path toward regulatory approval for its non-invasive, real-time saliva glucose test.
Read MoreSiemens Healthineer’s ELF Test performed the best of the five blood biomarkers selected for the FNIH NIMBLE Study.
Read MoreA needle-free technology that would allow people with diabetes to measure blood sugar levels has been bought closer to reality by researchers.
Read MoreThe FDA-cleared, POGO automatic blood glucose monitor features a 10-test cartridge for simplified testing.
Read MoreThe cordless DigiVibe device from BING Innovations uses vibration technology to ease the pain involved in finger-sticks for blood glucose monitoring.
Read MoreBio-Rad has launched an enhanced version of its Liquichek Diabetes Control to monitor the precision of hemoglobin testing associated with diabetes.
Read MoreNew research creates a road map for future treatments of nonalcoholic fatty liver disease and confirms the need for more mainstream screening.
Read MoreA glucose salivary test, designed to replace the invasive finger prick method, has been submitted to the FDA for Pre-Submission review.
Read MoreA new wearable device created by Penn State researchers, less intrusive glucose monitoring could become the norm.
Read MoreEKF Diagnostics is presenting its STAT-Site WB dual analyze measurement at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.
Read MorePhysician-scientists want to know if people with schizophrenia are also headed toward metabolic syndrome, which increases their risk of heart disease.
Read MoreLow-cost screen printed carbon sensors — used to rapidly detect bacteria commonly found in wounds — could pave the way for a real-time medical device.
Read MorePeople with type 2 diabetes should be considered in remission after sustaining normal blood sugar levels for three months or more.
Read More